Table II.
Clinical outcome | Total, n (%) | High LMO2 expression, n (%) | Low LMO2 expression, n (%) | P-value |
---|---|---|---|---|
Total | 85 (100.0) | 46 (46.0) | 39 (39.0) | |
Complete remission | 62 (72.9) | 38 (82.6) | 24 (61.5) | 0.03 |
Refractory disease | 12 (14.1) | 6 (13.0) | 6 (15.3) | 0.87 |
Mortality induction | 11 (12.9) | 2 (4.3) | 9 (23.0) | 0.03 |
Relapse risk | 25 (29.4) | 8 (17.3) | 17 (43.5) | 0.01 |
LMO2, LIM domain only protein 2.